tuberculosis%20-%20pulmonary%20(pediatric)
TUBERCULOSIS - PULMONARY (PEDIATRIC)
Tuberculosis (TB) is caused by Mycobacterium tuberculosis, a gram-positive bacteria with slow growth rate that is enhanced by 6-8% carbon dioxide and temperature of 35-40ºC.
It is primarily transmitted through airborne route.
The number of tubercle bacilli expelled in the air by a TB infected person is directly related to their infectiousness.
TB transmission is rare in children <10 years old due to their inability to expectorate sputum and low TB bacilli load in their sputum.
TB infection in children is usually obtained from an infectious adolescent or adult depending on the closeness and length of contact and the index case's severity of lung involvement and infectiousness.

Tuberculosis%20-%20pulmonary%20(pediatric) Patient Education

Patient Education

  • Educate the patient, parents & caregivers about pulmonary tuberculosis (PTB) & the importance of adherence to the prescribed treatment regimen
  • Consider referring patient for Daily Oral Treatment (DOT)
    • A treatment intervention where a patient’s actual intake of drugs is facilitated by a healthcare provider or a trained non-healthcare provider
    • Recommended to be performed in the community or in the patient’s residence rather than in a health-care center, clinic, hospital or any health-care establishments
  • Video-observed treatment (VOT) is an alternative to DOT
  • Patients have the benefit of availing one or more treatment adherence interventions [eg tracers (visits, calls,messaging), digital medication monitor, psychological counselling, material support (monetary incentives, food) & staff training] & choosing an accredited & convenient way of administering therapy
  • In patients with multidrug resistant tuberculosis (MDR-TB), decentralized type is preferred over a centralized type
  • Instruct patients & parents regarding symptoms suggesting adverse drug reactions & advise them to seek assistance when these occur
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 3 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Stephen Padilla, 4 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 3 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.